Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI106645

Effects of Nitroglycerin on Regional Myocardial Blood Flow in Coronary Artery Disease

Lawrence D. Horwitz, Richard Gorlin, Warren J. Taylor, and Harvey G. Kemp

Cardiovascular Division, Department of Medicine, Boston, Massachusetts 02115

Division of Thoracic and Cardiac Surgery, Department of Surgery, Peter Bent Brigham Hospital, Boston, Massachusetts 02115

Harvard Medical School, Boston, Massachusetts 02115

Find articles by Horwitz, L. in: JCI | PubMed | Google Scholar

Cardiovascular Division, Department of Medicine, Boston, Massachusetts 02115

Division of Thoracic and Cardiac Surgery, Department of Surgery, Peter Bent Brigham Hospital, Boston, Massachusetts 02115

Harvard Medical School, Boston, Massachusetts 02115

Find articles by Gorlin, R. in: JCI | PubMed | Google Scholar

Cardiovascular Division, Department of Medicine, Boston, Massachusetts 02115

Division of Thoracic and Cardiac Surgery, Department of Surgery, Peter Bent Brigham Hospital, Boston, Massachusetts 02115

Harvard Medical School, Boston, Massachusetts 02115

Find articles by Taylor, W. in: JCI | PubMed | Google Scholar

Cardiovascular Division, Department of Medicine, Boston, Massachusetts 02115

Division of Thoracic and Cardiac Surgery, Department of Surgery, Peter Bent Brigham Hospital, Boston, Massachusetts 02115

Harvard Medical School, Boston, Massachusetts 02115

Find articles by Kemp, H. in: JCI | PubMed | Google Scholar

Published August 1, 1971 - More info

Published in Volume 50, Issue 8 on August 1, 1971
J Clin Invest. 1971;50(8):1578–1584. https://doi.org/10.1172/JCI106645.
© 1971 The American Society for Clinical Investigation
Published August 1, 1971 - Version history
View PDF
Abstract

Regional myocardial blood flow before and after sublingual nitroglycerin was measured in 10 patients with coronary artery disease. During thoracotomy, 133Xe was injected directly into the subepicardium in diseased regions of the anterior left ventricular wall, and washout rates were recorded with a scintillation counter. All disappearance curves were closely approximated by two exponential decays analyzed as two parallel flow systems by the compartmental method. The appearance of a double exponential decay pattern in diseased regions suggests that the slow phase was associated with collateral blood flow, although nonhomogeneous myocardium-to-blood partition coefficients for xenon cannot be excluded. Nitroglycerin increased the rapid phase flow in 9 of 10 patients and the slow flow in 7 of 10 patients. Average flow increased in 9 of the 10 patients (P < 0.01). Mean rapid phase flow in the control state was 110 ml/100 g per min and after nitroglycerin increased to 132 ml/100 g per min (P < 0.01); slow phase flow increased from 12 ml/100 g per min to 15 ml/100 g per min (P < 0.05). It is concluded that, under these conditions, nitroglycerin improves perfusion in regions of diseased myocardium in patients with coronary artery disease.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1578
page 1578
icon of scanned page 1579
page 1579
icon of scanned page 1580
page 1580
icon of scanned page 1581
page 1581
icon of scanned page 1582
page 1582
icon of scanned page 1583
page 1583
icon of scanned page 1584
page 1584
Version history
  • Version 1 (August 1, 1971): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts